RxDoctor Payments DataLook up a doctor →

Mallu Reddy, MD

Internal Medicine · Pomona, CANPI 1942278221

Payments from drug & device makers

$6,861,310in general payments, 2019–2025

Across 1,000 payments — averaging $6861.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$6.5M
  • AstraZeneca$76K
  • Chiesi USA, Inc.$61K
  • Alnylam Pharmaceuticals Inc.$56K
  • Pfizer$56K
  • Novartis$29K
  • plus $75K from 53 others
$2,273in research payments, 2019–2025

Across 3 payments — averaging $757.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Chiesi USA, Inc.$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Modernatx, Inc.108$6,508,336
AstraZeneca68$76,339
Chiesi USA, Inc.20$60,766
Alnylam Pharmaceuticals Inc.56$56,088
Pfizer52$55,524
Novartis55$28,976
Currax Pharmaceuticals LLC5$26,249
Boehringer Ingelheim16$19,281
Boehringer Ingelheim Canada Ltd.ltee27$15,938
Lucid Diagnostics Inc.22$2,095
Johnson & Johnson64$1,216
Novo Nordisk69$1,209
Lilly USA, LLC42$889
Merck34$615
SK Life Science, Inc.26$598
Amgen(2 entities)39$595
Sanofi-aventis U.S. LLC40$576
Medtronic6$568
UCB, Inc.23$563
Bayer30$474
GSK21$449
Sunovion Pharmaceuticals Inc.23$426
Amarin Pharma, Inc.23$357
Eisai Inc.13$304
Sumitomo Pharma America, Inc.8$292
Vanda Pharmaceuticals Inc.9$272
AbbVie9$249
Esperion Therapeutics, Inc.5$205
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$199
Abbott3$180
Teva Pharmaceuticals USA, Inc.12$168
Otsuka America Pharmaceutical, Inc.6$146
Corium, LLC5$132
Dexcom, Inc.5$119
Biogen4$92
E.r. Squibb & Sons, L.L.C.5$86
Shield Therapeutics Inc3$72
Biohaven Pharmaceuticals, Inc.3$68
Mannkind Corporation4$57
Ardelyx, Inc.2$55
Biohaven Pharmaceutical Holding Company Ltd.2$51
Astellas Pharma US Inc2$44
Hologic Sales And Service, LLC2$40
Xeris Pharmaceuticals, Inc.2$39
Exact Sciences2$36
Averitas Pharma Inc.1$31
Optos, Inc.2$29
Urovant Sciences Inc1$24
Kyowa Kirin, Inc.1$23
Scilex Pharmaceuticals Inc.1$21
Regeneron Healthcare Solutions, Inc.1$20
Amryt Pharma Holdings Ltd1$19
Linus Health, Inc.1$19
Lundbeck LLC1$17
Amphastar Pharmaceuticals, Inc.1$17
Gilead1$15
Bard Peripheral Vascular, Inc.1$15
Neurelis, Inc.1$14
Venclose Inc.1$9

How this compares

$6,861,310 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Medicare billing

Part B allowed, 2024
$233,652
Medicare patients
312
Services billed
3,222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Pomona

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →